Magnetic resonance imaging (MRI) has emerged as a key component in modern radiotherapy. The superior soft tissue contrast compared to computed tomography (CT) allows for increased accuracy in the definition of both target and organs at risk using commonplace sequences.
Functional imaging techniques, primarily diffusion-weighted imaging and dynamic contrast enhanced imaging, are currently studied as a means of identifying areas within a tumor that require a higher dose in dose-painting trials.
Several current studies also aim to evaluate the possibilities of early treatment response assessment using MRI, which could enable treatment adaptation. At present, the main rationale of integrating MRI into the radiotherapy workflow is the gain in accuracy in target volume definitions. For several major patient groups, MR imaging is preferable from a medical point of view, i.e. for tumor definition. CT or CT equivalent information is still, however, required for the technical aspects of treatment planning such as:
• accurate dose calculations, which depend on knowledge of the attenuation properties of the tissue measured in a CT exam
• generation of reference images which are used for patient positioning based on in-room X-ray imaging.
Therefore, it is common practice to acquire both CT and MR data and align these image series in the same coordinate system, or frame of reference, through image registration. The MR data is used to define the target volume and the CT data to plan the treatment and serve as a reference for patient positioning. This workflow is, however, not optimal for several reasons. Besides the increase in cost and workload when using multiple imaging modalities, there is also an introduction of additional geometrical uncertainty due to the image registration.
We are evaluating three current synthetic CT techniques
1- Manual bulk density assignment
2- Atlas methods
3- Direct conversion
Aim 1. Correct for any MRI geometrical distortions (System and Patient specific), be sure to guarantee the spatial accuracy of tumor and normal tissue within a millimeter.
Aim 2. Generated synthetic computed tomography (Synthetic CT) images comparable with CT for dose calculation.
Aim 3. Assessing the Dosimetry Accuracy of Magnetic Resonance-Generated Synthetic CT Images for Focal Brain Radiation Therapy (VMAT, IMRT and SRS)
Purpose: This feasibility study investigated the dosimetric accuracy of synthetic-CT images derived from MR images for stand-alone intracranial focal brain treatment planning. Synthetic-CT images allow more accurate volume delineation resulting in better tumor control probability and normal tissue sparing. Initial results were compared to conventional CT-based and homogeneous patient density treatment plans.
Methods: MR and CT images were acquired for a brain patient. Synthetic-CT images were generated from MR images using a syngo.via Frontier prototype software (Siemens Healthcare). The physician defined target and normal tissues on a separate T1 MR image set, then both the synthetic-CT and MR images with structures were rigidly aligned to the CT. A VMAT SRT plan (25Gy in 5 fractions) was designed on the CT set (with and without heterogeneity correction), and the plan was transferred exactly to the synthetic-CT images. PTV coverage and hot spot along with normal tissue doses were analyzed, as well as gradient metrics. Finally, 2-dimensional analyses of dose distributions were performed using 1%/1mm gamma criteria.
Results: PTV coverage (V100) for the CT, synthetic-CT, and homogeneous calculations was 95.7%, 97.1%, and 99.1%, respectively. Normal tissue doses were comparable. R50% (V50%/V100%) values were 4.59, 4.45, and 4.32. Max doses were 29.8Gy, 30.3Gy, and 30.8Gy. Gamma analysis showed passing agreement of 97.6% and 96.8% for comparisons of the synthetic-CT and homogeneous calculation relative to the CT dose distribution, respectively.
Conclusions: Synthetic-CT compared favorably to the homogeneous calculation when analyzed relative to the CT image set. These initial feasibility study results indicate that accurate dose calculation from a MR generated synthetic-CT may be advantageous with the benefit of MR accurate structure delineation and dose calculation accuracy exceeding that achieved with a homogeneous density calculation. In addition, this study indicated that ignoring heterogeneity corrections in brain region could give the clinician false target coverage.